황련해독탕의 피부지방장벽개선을 통한 Th2 분화조절이 아토피피부염 완화에 미치는 효과

키워드

참고문헌 (36)

1. Engel-Yeger B, "Sensory processing patterns of adults with atopic dermatitis", J Eur Acad Dermatol Venereol, 25(2), pp.152~156 (2011)[DOI]
2. 오재원, "Epidemiological Change of Atopic Dermatitis and Food Allergy in School-Aged Children in Korea between 1995 and 2000", Journal of Korean Medical Science, 19(5), pp.716~723 (2004), 대한의학회
3. 지혜미, "2006년 초등학생의 알레르기 질환 유병률의 전국적 역학조사", Allergy Asthma & Respiratory Disease, 19(2), pp.165~172 (2009), 대한 소아알레르기 호흡기학회
4. 안강모, "2010년 한국 어린이·청소년의 천식, 알레르기 비결막염, 아토피피부염 증상 유병률 조사: 복합표본설계를 이용한 전국 서베이", 대한의사협회지, 54(7), pp.769~778 (2011), 대한의사협회
5. Kabashima K, "New concept of the pathogenesis of atopic dermatitis: interplay among the barrier, allergy, and pruritus as a trinity", J Dermatol Sci, 70(1), pp.3~11 (2013)[DOI]
6. Rousset F, "Shifts in interleukin-4 and interferon-gamma production by T cells of patients with elevated serum IgE levels and the modulatory effects of these lymphokines on spontaneous IgE synthesis", J Allergy Clin Immunol, 87(1), pp.58~69 (1991)[DOI]
7. van der Kleij HP, "Murine model for non-IgE-mediated asthma", Inflammation, 28(3), pp.115~125 (2004)[DOI]
8. 박양, "한국에서 아토피피부염 진단과 치료의 임상적 실태 조사", Allergy Asthma & Respiratory Disease, 1(3), pp.257~265 (2013), 대한 소아알레르기 호흡기학회
9. Callen J, "A systematic review of the safety of topical therapies for atopic dermatitis", Br J Dermatol, 156(2), pp.203~221 (2007)[DOI]
10. Pariser D, "Topical corticosteroids and topical calcineurin inhibitors in the treatment of atopic dermatitis: focus on percutaneous absorption", Am J Ther, 16(3), pp.264~273 (2009)[DOI]
11. 임광모, "알레르기성 질환에 대한 한의학적 접근", 동의생리병리학회지, 16(5), pp.1~839 (2002), 한의병리학회
12. Schneider L, "Atopic dermatitis: a practice parameter update 2012", J Allergy Clin Immunol, 131(2), pp.295~299 (2013)[DOI]
13. 기호필, "黃連解毒湯의 아토피 피부염 개선 效果", 대한한의학 방제학회지, 21(1), pp.80~90 (2013), 대한한의학방제학회
14. 김보애, "황련해독탕이 NC", Nga Mice에서 유발된 아토피 피부염에 미치는 영향, 2008, pp.23(2), 59~65[DOI]
15. Wahlgren CF, "Itch and atopic dermatitis: an overview", J Dermatol, 26(11), pp.770~779 (1999)[DOI]
16. Baron ED, "Atopic dermatitis management: comparing the treatment patterns of dermatologists in Japan, U.S.A. and U.K.", Br J Dermatol, 147(4), pp.710~715 (2002)[DOI]
17. Drake LA, "Relief of pruritus in patients with atopic dermatitis after treatment with topical doxepin cream. The Doxepin Study Group", J Am Acad Dermatol, 31(4), pp.613~616 (1994)[DOI]
18. Bonnel RA, "Allergic contact dermatitis from topical doxepin: Food and Drug Administration's postmarketing surveillance experience", J Am Acad Dermatol, 48(2), pp.294~296 (2003)[DOI]
19. Lassus A, "Clinical comparison of alclometasone dipropionate cream 0.05% with hydrocortisone butyrate cream 0.1% in the treatment of atopic dermatitis in children", J Int Med Res, 11(5), pp.315~319 (1983)[DOI]
20. Steinert PM, "Characterization of a class of cationic proteins that specifically interact with intermediate filaments", Proc Natl Acad Sci USA, 78(7), pp.4097~4101 (1981)[DOI]
21. 김현정, "아토피피부염과 피부 장벽 이상", Allergy Asthma & Respiratory Disease, 1(1), pp.20~28 (2013), 대한 소아알레르기 호흡기학회
22. Steinert PM, "The proteins elafin, filaggrin, keratin intermediate filaments, loricrin, and small proline-rich proteins 1 and 2 are isodipeptide cross-linked components of the human epidermal cornified cell envelope", J Biol Chem, 270(30), pp.17702~17711 (1995)[DOI]
23. Steinett PM, "Direct evidence that involucrin is a major early isopeptide cross-linked component of the keratinocyte cornified cell envelope", J Biol Chem, 272(3), pp.2021~2030 (1997)[DOI]
24. Kim BE, "Loricrin and involucrin expression is down-regulated by Th2 cytokines through STAT-6", Clin Immunol, 126(3), pp.332~337 (2008)[DOI]
25. Smith FJ, "Loss-of-function mutations in the gene encoding filaggrin cause ichthyosis vulgaris", Nat Genet, 38(3), pp.337~342 (2006)[DOI]
26. O'Regan GM, "The role of filaggrin in the atopic diathesis", Clin Exp Allergy, 40(7), pp.965~972 (2010)[DOI]
27. Cha HY, "Hataedock treatment has preventive therapeutic effects in atopic dermatitis-induced NC", Nga mice under high-fat diet conditions, 2016, pp.2016, 1739760~
28. Bruch-Gerharz D, "A proinflammatory activity of interleukin 8 in human skin: expression of the inducible nitric oxide synthase in psoriatic lesions and cultured keratinocytes", J Exp Med, 184(5), pp.2007~2012 (1996)[DOI]
29. Bruch-Gerharz D, "Nitric oxide and its implications in skin homeostasis and disease - a review", Arch Dermatol Res, 290(12), pp.643~651 (1998)[DOI]
30. Hatano Y, "Interleukin-4 suppresses the enhancement of ceramide synthesis and cutaneous permeability barrier functions induced by tumor necrosis factor-<TEX>${\alpha}$<", TEX> and interferon-<TEX>${\gamma}$<, J Invest Dermatol, pp.2005, 124(4)[DOI]
31. Albanesi C, "IL-4 and IL-13 negatively regulate TNF-<TEX>${\alpha}$<", TEX>-and IFN-<TEX>${\gamma}$<, TEX>-defensin expression through STAT-6, suppressor of cytokine signal- ing (SOCS)-1, and SOCS-3, pp.J Immunol, 2007[DOI]
32. Kubo A, "Epidermal barrier dysfunction and cutaneous sensitization in atopic diseases", J Clin Invest, 122(2), pp.440~447 (2012)[DOI]
33. Chung HY, "Molecular inflammation: underpinnings of aging and age-related diseases", Ageing Res Rev, 8(1), pp.18~30 (2009)[DOI]
34. Baeuerle PA, "NF-kappa B: ten years after", Cell, 87(1), pp.13~20 (1996)[DOI]
35. Aktan F, "iNOS-mediated nitric oxide production and its regulation", Life Sci, 75(6), pp.639~653 (2004)[DOI]
36. Aktan F, "Gypenosides derived from Gynostemma pentaphyllum suppress NO synthesis in murine macrophages by inhibiting iNOS enzymatic activity and attenuating <TEX>$NF-{\kappa}B$<", TEX>-mediated iNOS protein expression, 2003, pp.8(4), 235~242

관련 논문AI추천